Type 1/Type 2 Immunity in Infectious Diseases
Open Access
- 1 January 2001
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (1), 76-102
- https://doi.org/10.1086/317537
Abstract
T helper type 1 (Th1) lymphocytes secrete secrete interleukin (IL)-2, interferon-γ, and lymphotoxin-α and stimulate type 1 immunity, which is characterized by intense phagocytic activity. Conversely, Th2 cells secrete IL-4, IL-5, IL-9, IL-10, and IL-13 and stimulate type 2 immunity, which is characterized by high antibody titers. Type 1 and type 2 immunity are not strictly synonymous with cell-mediated and humoral immunity, because Th1 cells also stimulate moderate levels of antibody production, whereas Th2 cells actively suppress phagocytosis. For most infections, save those caused by large eukaryotic pathogens, type 1 immunity is protective, whereas type 2 responses assist with the resolution of cell-mediated inflammation. Severe systemic stress, immunosuppression, or overwhelming microbial inoculation causes the immune system to mount a type 2 response to an infection normally controlled by type 1 immunity. In such cases, administration of antimicrobial chemotherapy and exogenous cytokines restores systemic balance, which allows successful immune responses to clear the infection.Keywords
This publication has 390 references indexed in Scilit:
- The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequenciesJournal of Hepatology, 1999
- Bacterial DNA-Induced NK Cell IFN-γ Production Is Dependent on Macrophage Secretion of IL-12Clinical Immunology and Immunopathology, 1997
- Interleukin-10 gene knock-out mice: a model of chronic inflammationClinical Immunology and Immunopathology, 1995
- Immunologic characterization of children vertically infected with human immunodeficiency virus, with slow or rapid disease progressionThe Journal of Pediatrics, 1995
- Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous diseaseThe Journal of Pediatrics, 1994
- Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skinJournal of the American Academy of Dermatology, 1994
- Saying the ‘S’ word in publicImmunology Today, 1993
- Disruption of the murine IL-4 gene blocks Th2 cytokine responsesNature, 1993
- Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cellsClinical Immunology and Immunopathology, 1991
- Plasma norepinephrine in congestive heart failureThe American Journal of Cardiology, 1978